Clinical trial

ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment

NCT02735863

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention ABX464 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-05-01

PhasePHASE2

Conditions

HIV Infectionverified · MONDO: HIV infectious disease

Interventions

ABX464DRUG

PlaceboDRUG

Sponsors & collaborators

Abivax S.A.lead sponsor

Mapped research locations

BarcelonaSpain3 MontpellierFrance1 BrusselsBelgium1 LyonFrance1 GhentBelgium1 LiègeBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02735863 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.